首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Quantitative and qualitative analysis of coagulation factors in cryoprecipitate prepared from fresh-frozen plasma inactivated with amotosalen and ultraviolet A light
【24h】

Quantitative and qualitative analysis of coagulation factors in cryoprecipitate prepared from fresh-frozen plasma inactivated with amotosalen and ultraviolet A light

机译:由阿托莫素和紫外线A灭活的新鲜冷冻血浆制备的冷沉淀物中凝血因子的定量和定性分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: There were no previous studies about the quality of cryoprecipitate prepared from fresh-frozen plasma (FFP) inactivated with amotosalen and ultraviolet A (UVA) light. The aim of this study was to analyze the quantity and quality of coagulation factors in cryoprecipitate prepared from FFP treated with amotosalen and UVA light. Study Desing and Methods: FFP was obtained from whole blood donations and inactivated with amotosalen and UVA light according to the manufacturer's instructions. Fibrinogen, factor VIII (FVIII), von Willebrand factor antigen (VWF: Ag) and activity (VWF: RCo), the von Willebrand factor cleavage protease activity (ADAMTS-13), and the multimeric structure of VWF were analyzed. Results: The content of fibrinogen, FVIII, and ADAMTS-13 was lower in cryoprecipitates prepared from amotosalen-treated plasma when compared with cryoprecipitates prepared from nontreated plasma (35, 40, and 18% loss, respectively). The quantity and quality of VWF as well as VWF multimer patterns were not affected by the inactivation method. Conclusion: Cryoprecipitates prepared from amotosalen-treated FFP contained significantly reduced levels of fibrinogen, FVIII, and ADAMTS-13. However, the VWF quantity and quality was well preserved. ? 2012 American Association of Blood Banks.
机译:背景:以前没有关于用阿莫沙仑和紫外线A(UVA)灭活的新鲜冷冻血浆(FFP)制备的冷沉淀物质量的研究。这项研究的目的是分析用Amotosalen和UVA光处理的FFP制备的冷沉淀物中凝血因子的数量和质量。研究目的和方法:FFP是从全血中获得的,并根据制造商的说明用Amotosalen和UVA灯灭活。分析了纤维蛋白原,VIII因子(FVIII),von Willebrand因子抗原(VWF:Ag)和活性(VWF:RCo),von Willebrand因子裂解蛋白酶活性(ADAMTS-13)和VWF的多聚体结构。结果:与未经处理的血浆制备的冷沉淀相比,用阿托莫素处理过的血浆制备的冷沉淀中的纤维蛋白原,FVIII和ADAMTS-13含量更低(分别损失35%,40%和18%)。 VWF的数量和质量以及VWF多聚体模式不受灭活方法的影响。结论:由阿托莫素处理过的FFP制备的冷冻沉淀物显着降低了纤维蛋白原,FVIII和ADAMTS-13的水平。但是,VWF的数量和质量得到了很好的保留。 ? 2012年美国血库协会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号